<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Ayu</journal-id><journal-id journal-id-type="iso-abbrev">Ayu</journal-id><journal-id journal-id-type="publisher-id">AYU</journal-id><journal-title-group><journal-title>Ayu</journal-title></journal-title-group><issn pub-type="ppub">0974-8520</issn><issn pub-type="epub">0976-9382</issn><publisher><publisher-name>Medknow Publications &#x00026; Media Pvt Ltd</publisher-name><publisher-loc>India</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">23723641</article-id><article-id pub-id-type="pmc">3665088</article-id><article-id pub-id-type="publisher-id">AYU-33-356</article-id><article-id pub-id-type="doi">10.4103/0974-8520.108822</article-id><article-categories><subj-group subj-group-type="heading"><subject>Clinical Research</subject></subj-group></article-categories><title-group><article-title>Clinical study of <italic>Tribulus terrestris</italic> Linn. in Oligozoospermia: A double blind study</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Sellandi</surname><given-names>Thirunavukkarasu M.</given-names></name><xref ref-type="aff" rid="aff1"/><xref ref-type="corresp" rid="cor1"/></contrib><contrib contrib-type="author"><name><surname>Thakar</surname><given-names>Anup B.</given-names></name><xref ref-type="aff" rid="aff2">1</xref></contrib><contrib contrib-type="author"><name><surname>Baghel</surname><given-names>Madhav Singh</given-names></name><xref ref-type="aff" rid="aff3">2</xref></contrib></contrib-group><aff id="aff1">Lecturer, Government Ayurveda Medical College and Hospital, Nagercoil, Tamil Nadu, India</aff><aff id="aff2"><label>1</label>Associate Professor and I/C Head, Department of Panchakarma, Institute for Post Graduate Teaching and Research in Ayurveda, Gujarat Ayurved University, Jamnagar, Gujarat, India</aff><aff id="aff3"><label>2</label>Director, Institute for Post Graduate Teaching and Research in Ayurveda, Gujarat Ayurved University, Jamnagar, Gujarat, India</aff><author-notes><corresp id="cor1"><bold>Address for correspondence:</bold> Dr. M. S. Thirunavukkarasu, Govt. Ayurveda Medical College and Hospital, Kottar, Nagercoil - 629 002, Tamil Nadu, India. E-mail: <email xlink:href="thiru.dr@gmail.com">thiru.dr@gmail.com</email></corresp></author-notes><pub-date pub-type="ppub"><season>Jul-Sep</season><year>2012</year></pub-date><volume>33</volume><issue>3</issue><fpage>356</fpage><lpage>364</lpage><permissions><copyright-statement>Copyright: &#x000a9; AYU (An International Quarterly Journal of Research in Ayurveda)</copyright-statement><copyright-year>2012</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-sa/3.0"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><p>Infertility is a problem of global proportions, affecting on an average 8-12% of couples worldwide. Low sperm count (Oligozoospermia) is one of the main causes of male infertility and it is correlated with <italic>Kshina Shukra</italic>. The fruits of <italic>Gokshura</italic> (<italic>Tribulus terrestris</italic>. Linn) are considered to act as a diuretic and aphrodisiac; they used for urolithiasis, sexual dysfunctions, and infertility. Hence, it was planned to study the effect of <italic>Gokshura</italic> in the management of <italic>Kshina Shukra</italic> (Oligozoospermia), and to evade the preconception, a double-blind, randomized, placebo-controlled study was designed. In this study, eligible subjects between the age of 21 and 50 years, with a complaint of <italic>Kshina Shukra</italic> (Oligozoospermia), were randomized to receive either <italic>Gokshura</italic> granules or placebo granules for 60 days. The primary outcome measures were percentage changes in the <italic>Pratyatmaka Lakshanas</italic> (cardinal symptoms) of <italic>Kshina Shukra</italic>, <italic>Agni bala</italic>, <italic>Deha bala</italic>, <italic>Satva bala</italic>, the semenogram, and in the Quality of the Sexual Health Questionnaire. The placebo granules showed 70.95% improvement, whereas, the <italic>Gokshura</italic> granules showed 78.11% improvement in <italic>Rogi bala</italic> (<italic>Agni bala</italic>, <italic>Deha bala</italic>, <italic>Satva bala</italic>, and the Quality of Sexual Health) and <italic>Rogabala</italic> (Semen Analysis and <italic>Pratyatmaka Lakshanas</italic>). The <italic>Gokshura</italic> granules have shown superior results in the management of <italic>Kshina Shukra</italic>, as compared to the placebo granules.</p></abstract><kwd-group><kwd><italic>Gokshura</italic></kwd><kwd><italic>Kshina Shukra</italic></kwd><kwd>Oligozoospermia</kwd><kwd><italic>Tribulus terrestris</italic></kwd></kwd-group></article-meta></front><body><sec id="sec1-1"><title>Introduction</title><p>Infertility is a problem of global proportions, affecting on an average 8-12% of couples worldwide.[<xref ref-type="bibr" rid="ref1">1</xref>] Based on the National Women's Health Information Center (NWHIC), the annual incidence of male infertility is at least two million cases. Recent studies have indicated that the prevalence of Oligozoospermia is extremely high in the metropolis as well as in the smaller towns of India.[<xref ref-type="bibr" rid="ref2">2</xref>]</p><p>Infertility is defined as the inability to achieve pregnancy after one year of unprotected coitus.[<xref ref-type="bibr" rid="ref3">3</xref>] Male infertility is considerably to be less complicated than female infertility, but can account for 30-40% of infertility.[<xref ref-type="bibr" rid="ref4">4</xref>] Except for some physical defects, low sperm count (Oligozoospermia) and poor sperm quality are responsible for male infertility in more than 90% of the cases. Out of these, in about 30 to 40% the cause is unexplained, and in the rest of the cases critical illness, malnutrition, genetic abnormalities, pollution, side effects of some medicines, hormones, and chemicals play a major role.[<xref ref-type="bibr" rid="ref5">5</xref>]</p><p>More than 190 studies on <italic>Vajikarana</italic> (Aphrodisiac therapy)[<xref ref-type="bibr" rid="ref6">6</xref>] have been carried out in various Ayurvedic Academic Institutes in India, at the PG and PhD level, wherein, researchers have considered various aspects of the problem, like its etiology, pathogenesis, and complications of the diseases related to the reproductive system, in both Ayurvedic and Modern parlance. Out of 190 studies more than 50 studies have been carried out on Oligozoospermia. The term Oligozoospermia is correlated in the research studies with <italic>Kshina Shukra</italic> (23 studies); <italic>Alpa Shukra</italic> (1 study); <italic>Shukra Dosha</italic> (3 studies); <italic>Shukra Dushti</italic> (13 studies); <italic>Shukra Kshaya</italic> (11 studies); <italic>Shukralpata</italic> (3 studies); <italic>Kshina Retas</italic> (1 study); <italic>Bijopaghata</italic> (1 study), and <italic>Shukradhatu Vikara</italic> (3 studies). <italic>Acharya Susruta</italic> has included <italic>Kshina Shukra</italic> under <italic>Shukra Dushti</italic>. Here, <italic>Vata dosha</italic> along with <italic>Pitta undergo</italic> vitiation and create a disturbance in the normal qualities and quantity of the <italic>Shukra Dhatu</italic>.[<xref ref-type="bibr" rid="ref7">7</xref>] Oligozoospermia is a seminal disorder in which the sperm count is below 20 million/ml.[<xref ref-type="bibr" rid="ref8">8</xref>]</p><p>However, it is evident that several studies were conducted on this subject, but only few studies have been carried out to recognize the clinical efficacy of single herbs, in this subject. <italic>Gokshura</italic> (<italic>Tribulus terrestris</italic>) is mentioned as a <italic>Vrishya</italic> (Aphrodisiac)[<xref ref-type="bibr" rid="ref9">9</xref>] and also used in almost all prescriptions, along with other drugs, to treat the malady <italic>Kshina Shukra</italic>. Studies have suggested that <italic>Gokshura</italic> can enhance the hormone levels to within a normal range. It can increase the testosterone by increasing the luteinizing hormone and the gonadotropin-releasing hormone.[<xref ref-type="bibr" rid="ref10">10</xref>] This hormone is effective in building muscles as well as improving fertility and libido, and it has also been proved to be active in stimulating spermatogenesis and sertoli cell activity in rats.[<xref ref-type="bibr" rid="ref11">11</xref>] However, to generate an evidence based on this, this clinical study has been carried out on <italic>Gokshura</italic> for the role of <italic>Vrishya</italic> (Aphrodisiac).[<xref ref-type="bibr" rid="ref12">12</xref>]</p></sec><sec id="sec1-2"><title>Aim of Study</title><p>The aim of this study is to find out the effect of <italic>Gokshura</italic> in the management of <italic>Kshina Shukra</italic> (Oligozoospermia).</p></sec><sec id="sec1-3"><title>Hypothesis</title><p><italic>Gokshura</italic> is not effective in the management of <italic>Kshina Shukra</italic> as a Null Hypothesis. However, it is effective in the management of <italic>Kshina Shukra</italic> as an Alternate Hypothesis.</p></sec><sec sec-type="materials|methods" id="sec1-4"><title>Materials and Methods</title><p>The methodology used for this study is explained as per the Consolidated Standards of Reporting Trials (CONSORT) Statement, 2010.[<xref ref-type="bibr" rid="ref13">13</xref>]</p><p>A total of 72 patients with <italic>Kshina Shukra</italic> were selected from the Outpatient Department of the Institute for Postgraduate Teaching and Research Hospital, Gujarat Ayurved University, Jamnagar. The patients were divided into two groups, by following the Computer-Generated Randomization Plan. Out of them, 63 patients completed the treatment and they were divided into two groups &#x02014; Group A &#x02013; 31 patients and Group B &#x02013; 32 patients &#x02014; taking into consideration the inclusion and exclusion criteria.</p><sec id="sec2-1"><title>Inclusion criteria</title><p>
<list list-type="bullet"><list-item><p>Age group between 21 to 50 years</p></list-item><list-item><p>Sperm count &#x0003c; 20 million/ml</p></list-item><list-item><p>Patients presenting with <italic>Pratyatmaka Lakshana</italic> (Cardinal Symptoms) of <italic>Kshina Shukra</italic>, with semen samples suggestive of Oligozoospermia, were selected.</p></list-item></list>
</p></sec><sec id="sec2-2"><title>Exclusion criteria</title><p>
<list list-type="bullet"><list-item><p>Age below 21 or above 50 years</p></list-item><list-item><p>Sperm count &#x0003e; 20 million/ml</p></list-item><list-item><p>Patients with azoospermia and aspermia</p></list-item><list-item><p>Genetic defects like Klinefelter's syndrome</p></list-item><list-item><p>Patients with diseases like varicocele, accessory sex gland infection, sexually transmitted diseases, systemic diseases like diabetes mellitus (DM), and so on, were excluded from this study.</p></list-item></list>
</p></sec><sec id="sec2-3"><title>Laboratory investigations</title><p>Routine hematological, biochemical, and urine examination, semen analysis, and Serum follicle-stimulating hormone (FSH), Serum luteinizing hormone (LH), and Serum Testosterone were carried out before and after the treatment, and a semenogram was carried out before treatment, on the thirtieth, sixtieth, and ninetieth, days of the study.</p></sec><sec id="sec2-4"><title>Ethical clearance</title><p>Ethical clearance was obtained from the Institutional Ethics Committee of IPGT and RA Jamnagar; Vide Ref-PGT/7/Ethics/2009-2010/3494/15 Dated: 8 February, 2010, before starting the study, and this study was registered in the Clinical Trial Registry of India, vide CTRI/2011/07/001907.[<xref ref-type="bibr" rid="ref14">14</xref>]</p></sec><sec id="sec2-5"><title>Blinding</title><p>The prepared drugs were blinded and labeled as Group A and Group B by the Department of <italic>Rasa Shastra</italic> as the study was designed as a Double-blind Randomized Placebo-controlled study.</p></sec><sec id="sec2-6"><title>Method of allocation concealment</title><p>Both drugs in granule form were given, 6 g twice daily, before food, in the morning and night, with warm water, for 60 days.</p><p>Before dispensing the medicine, <italic>Koshtha Shuddhi</italic> (bowel cleansing therapy) was carried out with 20 ml of <italic>Eranda Taila</italic> (oil of <italic>Ricinus communis</italic>), in both the groups. After <italic>Koshtha Shuddhi</italic> (bowel cleansing therapy), a light diet was advised on the same day. The following day onwards the patients were given medicine and also allowed to take a normal diet.</p></sec><sec id="sec2-7"><title>Follow-up</title><p>The patients were advised to visit the hospital every fortnight during the treatment and for one month after the treatment for follow-up.</p></sec><sec id="sec2-8"><title>Criteria for assessment</title><p>The improvement in the patients was assessed mainly on the basis of relief in the signs and symptoms of <italic>Kshina Shukra</italic> (Oligozoospermia), improvement in the semenogram, especially in the total sperm count, and also in the serum FSH, LH, and testosterone level, improvement in <italic>Deha Bala</italic>, <italic>Chetasa Bala</italic> and <italic>Agni Bala</italic>, and improvement in the Quality of Sexual Life Questionnaire.[<xref ref-type="bibr" rid="ref15">15</xref>]</p><p>Arbitration of criteria considered for assessment in the interpretation of results was as follows;</p><p>
<list list-type="bullet"><list-item><p><italic>Roga Bala</italic>: 70% &#x02013; Semen Analysis &#x02013; 50%; <italic>Lakshanas</italic> &#x02013; 20%</p></list-item><list-item><p><italic>Rogi Bala</italic>: 30% &#x02013; <italic>Agni Bala</italic> &#x02013; 5%; <italic>Deha Bala</italic> &#x02013; 5%; <italic>Chetsa Bala</italic> &#x02013; 5%; Sexual Quality of Life (QoL) &#x02013; 15%</p></list-item></list>
</p><p><bold>A. <italic>Roga Bala</italic>:</bold>
<italic>Roga Bala</italic> was used to assess the signs and symptoms of <italic>Kshina Shukra</italic>. The details of the scoring pattern adopted for the assessment of the clinical signs and symptoms are given in <xref ref-type="table" rid="T1">Table 1</xref>.</p><table-wrap id="T1" position="float"><label>Table 1</label><caption><p>Scoring pattern of <italic>Roga Bala</italic></p></caption><graphic xlink:href="Ayu-33-356-g001"/></table-wrap><p><bold>B. <italic>Rogi bala</italic>:</bold>
<italic>Rogi bala</italic>, was assessed for any improvement in the Sexual QoL and in the symptoms of <italic>Agni Bala</italic>, <italic>Deha Bala</italic>, as well as <italic>Chetasa Bala</italic>, and the scoring patterns adopted are given in [<xref ref-type="table" rid="T2">Table 2</xref>].</p><table-wrap id="T2" position="float"><label>Table 2</label><caption><p>Scoring pattern of <italic>Rogi Bala</italic></p></caption><graphic xlink:href="Ayu-33-356-g002"/></table-wrap></sec><sec id="sec2-9"><title>Statistical analysis</title><p>The data generated in the clinical study was analyzed by applying the student's &#x02018;<italic>t</italic>&#x02019; test[<xref ref-type="bibr" rid="ref16">16</xref>] in the subjective and objective criteria of a single group, and to compare the effect of the therapy on the two groups. The obtained results were interpreted as:</p><p>
<list list-type="bullet"><list-item><p>Not significant (NS) : <italic>P</italic> &#x0003e; 0.05</p></list-item><list-item><p>Significant (S) : <italic>P</italic> &#x0003c; 0.05 or <italic>P</italic> &#x0003c; 0.01</p></list-item><list-item><p>Highly significant (HS) : <italic>P</italic> &#x02264; 0.001</p></list-item></list>
</p></sec><sec id="sec2-10"><title>Observations</title><p>The following flowchart depicts the figures of the clinical study. One hundred and fifty-two patients were screened during this study. Among them 80 patients were excluded, as they did not fulfill the eligibility criteria. Seventy-two patients fulfilling the eligibility criteria were randomly allocated by, using the Computerized Randomization Plan, into two groups, Group A with 37 patients and Group B with 35 patients, and were given intervention.</p><p>In Group A, out of 37 patients, six discontinued and in Group B, three patients discontinued out of 35; due to various reasons. Finally, the statistical analysis was completed on 63 patients, of which 31 patients belonged to Group A and 32 patients belonged to Group B.</p><p>In this study, the maximum number of patients belonged to the 21-30 years age group (46.25%), belonging to the Hindu religion (93.05%). They belonged to the lower middle class (45.83%), had primary level education (27.7%), were laborers (43.06%), and were exposed to occupational heat (59.72%). The maximum number of patients had <italic>Mandagni</italic> (43.05%) and <italic>Kapha Vata Prakruti</italic> (54.17%). All the patients of this study wer e found with a well-developed secondary character and they had a good relationship with their respective partners (94.44%).</p><p>The maximum number of patients were habituated to tobacco (58.33%) and most of the patients wore cotton undergarments (80.77%), tight underwear (67.31%), had a habit of warm water bath (37.5%), were mentally depressed (30.56%), were unaware of the fertility period (38.89%); and practiced <italic>Vegadharana</italic> (Suppression of urges) (83.33%).</p><p>It was observed that the maximum number of patients had primary infertility (66.67%) with severe oligozoospermic conditions (26.39%) for one to three years of chronicity (43.75%). With respect to symptoms of <italic>Kshina Shukra</italic> reported by the patients, they were <italic>Daurbalya</italic> (weakness), 52.78% <italic>Mukha Sosha</italic> (Dryness of Mouth), 47.22% <italic>Linga Shaithilya</italic> (Loss of Penile rigidity), and 45.83% <italic>Klaibya</italic> (Erectile dysfunction).</p></sec></sec><sec sec-type="results" id="sec1-5"><title>Results</title><sec id="sec2-11"><title>Effect of therapy on symptoms</title><p>Group A: The granules provided a highly and statistically significant (<italic>P</italic> &#x0003c; 0.001) result in the case of <italic>Daurbalya</italic> (weakness) (48.14%), and significant (<italic>P</italic> &#x0003c; 0.05) results in cases of loss of penile erection (6.03%), loss of penile rigidity (9.41%), premature ejaculation (6.12%), lack of orgasm (9.76%), and performance anxiety (8.69%). The results were insignificant (<italic>P</italic> &#x0003e; 0.05) in the case of post-act exhaustion (1.33%), frequency of coitus (2.08%), <italic>Mukha Sosha</italic> (dryness of mouth) (6.66%), and depression (22.22%). However, Group B granules provided a highly and statistically significant (<italic>P</italic> &#x0003c; 0.001) result in <italic>Daurbalya</italic> (weakness) (78.26%), loss of penile erection (9.44%), loss of penile rigidity (17.02%), premature ejaculation (10.68%), lack of orgasm (13.54%), and post-act exhaustion (13.33%). Significant (<italic>P</italic> &#x0003c; 0.05) results were observed in frequency of coitus (18.36%) and performance anxiety (10.81%) and insignificant (<italic>P</italic> &#x0003e; 0.05) results in <italic>Mukha Sosha</italic> (Dryness of mouth) (18.75%) and depression (15.38%).</p></sec><sec id="sec2-12"><title>Effect of therapy in <italic>Agni bala</italic>, <italic>Deha bala</italic>, and <italic>Satva bala</italic></title><p>Group A granules provided a highly statistically significant (<italic>P</italic> &#x0003c; 0.001) result giving <italic>Abhyavaharana Shakti</italic> (20.45%), <italic>Jarana Shakti</italic> (21.92%), <italic>Ruchi Hi Aharakale</italic> (12.05%), <italic>Balavriddhi</italic> (15.38%), <italic>Svaravarna Yoga</italic> (19.18%), a significant (<italic>P</italic> &#x0003c; 0.05) result in <italic>Sukhena Cha Pratibodhanam</italic> (8.57%), and <italic>Mano Buddhi Indriya Avyapatti</italic> (8.82%); and an insignificant (<italic>P</italic> &#x0003e; 0.05) result in <italic>Vata Mutra Purisha Retasam Mukti</italic> (7.5%), <italic>Sharira Upachaya</italic> (1.09%), and <italic>Nidra Labho yathakalam</italic> (5.56%). However, Group B Granules provided a highly statistically (<italic>P</italic> &#x0003c; 0.001) significant result giving <italic>Abhyavaharana Shakti</italic> (32.29%), <italic>Jarana Shakti</italic> (20.51%), <italic>Ruchi Hi Aharakale</italic> (19.04%), <italic>Balavriddhi</italic> (25.67%), <italic>Svaravarna Yoga</italic> (22.53%), a significant (<italic>P</italic> &#x0003c; 0.05) result in <italic>Vata Mutra Purisha Retasam Mukti</italic> (13.63%), <italic>Sukhena cha Pratibodhanam</italic> (7.57%), and <italic>Mano Buddhi Indriya Avyapatti</italic> (8.82%); and an insignificant (<italic>P</italic> &#x0003e; 0.05) result in <italic>Sharira Upachaya</italic> (1.11%) and <italic>Nidra Labho Yathakalam</italic> (7.84%).</p></sec><sec id="sec2-13"><title>Effect of therapy in hematological and biochemical parameters</title><p>There were no statistically significant changes (<italic>P</italic> &#x0003e; 0.05) in all hematological parameters like Hemoglobin, total red blood cell (RBC) count, total leukocyte count, and in the differential count in both the granules, as well as, in the biochemical parameters like fasting blood sugar (FBS), S. Cholesterol, S. Triglycerides, serum glutamic oxaloacetic transaminase (SGOT), serum glutamic pyruvic transaminase (SGPT), Total Protein, and so on. However, there was a change from the pre-test to post-test mean values of the above parameters, which was within the physiological limits. There was a statistically insignificant difference found in all of these parameters (<italic>P</italic> &#x0003e; 0.05). The difference found between the two groups was statistically insignificant. This proves that there was no adverse effect of the treatment.</p></sec><sec id="sec2-14"><title>Effect of therapy in hormones</title><p>S. Testosterone and S. FSH had decreased from 555.613 to 530.457 (4.53%&#x02193;), and 8.401 to 6.937 (17.42%&#x02193;), respectively, and S. LH had increased from 5.554 to 6.314 (13.7%&#x02191;) after treatment, in the Group A granules. However, the Group B granules had increased S. Testosterone from 515.69 to 599.81 (16.3%&#x02191;) and decreased S. FSH and S.LH from 10.812 to 6.998 (35.3%&#x02193;) and 6.673 to 4.444 (33.4%&#x02193;), respectively. There was a statistically insignificant difference found in all of these parameters (<italic>P</italic> &#x0003e; 0.05). On comparing the two groups on the effect of therapy on the hormones, it showed that it was statistically insignificant (<italic>P</italic> &#x0003e; 0.05) [<xref ref-type="fig" rid="F1">Figure 1</xref>].</p><fig id="F1" position="float"><label>Figure 1</label><caption><p>Effect of therapy on hormone</p></caption><graphic xlink:href="Ayu-33-356-g003"/></fig></sec><sec id="sec2-15"><title>Effect of therapy in seminal parameter</title><p>The percentage of relief in Seminal Parameters like Sperm total count was 104.2%, and 25.42% in abnormal forms. Although Motility, RLP (Rapid Linear progressive), SLP (Slow Linear progressive), and NP (Non-progressive) had decreased, they were 12.05, 14.83, 16.55, and 18.45%, respectively. When subjected to statistical analysis, The total sperm count was found to be statistically significant, that is, <italic>P</italic> &#x0003c; 0.01. The remaining parameters were statistically insignificant in the Group A granules, whereas, in the Group B granules, percentage of relief in Seminal Parameters like Liquefaction time, volume, sperm total count, motility, RLP, SLP, NP, and abnormal forms was 3.32, 12.9, 86.31, 7.89, 20.1, 3.33, 7.53, and 12.25%, respectively. After subjecting the data to statistical analysis, the total sperm count and abnormal forms were found to be statistically highly significant (<italic>P</italic> &#x02264; 0.001). RLP was observed to be statistically significant, that is, <italic>P</italic> &#x0003c; 0.05 [<xref ref-type="fig" rid="F2">Figure 2</xref>].</p><fig id="F2" position="float"><label>Figure 2</label><caption><p>Effect of therapy on seminal parameters</p></caption><graphic xlink:href="Ayu-33-356-g004"/></fig><p>In both groups, the total sperm count was recorded before treatment, at the end of the first, second, and third month, it was analyzed by the Kruskal-Wallis One Way Analysis of Variance on the Ranks test and it was observed that there was a statistically significant difference in both the groups, i.e. (<italic>P</italic> &#x0003c; 0.01). Even though, both the drugs increased the total sperm count on comparing the effect of therapy between the two groups, there was no statistically significant difference found (<italic>P</italic> &#x0003e; 0.05).</p></sec><sec id="sec2-16"><title>Effect of therapy on quality of sexual health</title><p>Group A granules provided 27.80% improvement and in Group B granules, 49.38% improvement was observed, which was highly significant (<italic>P</italic> &#x02264; 0.001). On comparing, there was a statistically significant difference found (<italic>P</italic> &#x0003c; 0.05) between both groups in the domain of sexual life, psychosexual, and Global index [<xref ref-type="fig" rid="F3">Figure 3</xref>].</p><fig id="F3" position="float"><label>Figure 3</label><caption><p>Effect of therapy on quality of sexual life</p></caption><graphic xlink:href="Ayu-33-356-g005"/></fig></sec><sec id="sec2-17"><title>Overall effect of the therapy</title><p>Group A granules, showed 70.95% improvement and Group B Granules showed 78.11% improvement in <italic>Rogi bala</italic> (<italic>Agni bala</italic>, <italic>Deha bala</italic>, <italic>Satva bala</italic>, and Sexual QoL) and <italic>Rogabala</italic> (Semen Analysis and <italic>Lakshanas</italic>). One patient having Group A granules and two patients having Group B granules were able to impregnate their partners in the second month of treatment [<xref ref-type="fig" rid="F4">Figure 4</xref>].</p><fig id="F4" position="float"><label>Figure 4</label><caption><p>Overall effect of therapy</p></caption><graphic xlink:href="Ayu-33-356-g006"/></fig></sec></sec><sec sec-type="discussion" id="sec1-6"><title>Discussion</title><p>The etiological factors classified under various headings such as chromosomal anomalies (<italic>Bijadosha</italic>) have been postulated to be one of the principal genetic factors in male infertility. These disorders occur due to the vitiation of the <italic>Bijabhaga</italic> of parents, which is responsible for the formation of <italic>Bija</italic> in the fetus.[<xref ref-type="bibr" rid="ref17">17</xref>] Several somatic chromosomal abnormalities are associated with male infertility. A specific defect in the male sex (Y) chromosome can cause the common form of male infertility, that is, oligozoospermia.[<xref ref-type="bibr" rid="ref18">18</xref>] Certain genetic disorders that cause oligozoospermia are Klinefelter's Syndrome, Kallmann's syndrome, Reifenstein's Sydrome, Testicular Malposition (Cryptorchidism), and so on.</p><p>Dietetic factors are described as <italic>Shukravaha Srotodushtikara Nidanas</italic>, particularly <italic>Anasana</italic> (Fasting),[<xref ref-type="bibr" rid="ref19">19</xref>] <italic>Alpa-Pramitaasana</italic> (Inadequate diet),[<xref ref-type="bibr" rid="ref20">20</xref>] and <italic>Visamaasana</italic> (Irregular diet),[<xref ref-type="bibr" rid="ref21">21</xref>] which can impede the <italic>agni</italic> and may produce <italic>Shukradushti</italic>, which ultimately leads to impaired fertility. Deprived sustenance may alter the metabolism, which may result in <italic>dhatu kshaya</italic>. <italic>Shukra</italic> is the essence of all the former <italic>dhatus</italic>. Thus, any disturbances in the digestive process may lead to defective formation of <italic>Shukra</italic>, that is, <italic>Majjakshaya</italic> leads to <italic>Alpa Shukra</italic>.[<xref ref-type="bibr" rid="ref22">22</xref>] Very low caloric or protein deficiency causes hypogonadism and decreases the function of the Leydig cell and further leads to infertility.[<xref ref-type="bibr" rid="ref23">23</xref>] <italic>Kshara</italic> (Alkali), <italic>lavana</italic> (Salt), and <italic>Amla</italic> (Sour)[<xref ref-type="bibr" rid="ref24">24</xref>] may cover the drugs of chemicals/pesticides described in modern medicine. The factors can be listed as <italic>Khavaigunyakara</italic> for <italic>Shukravaha srotas</italic>.</p><p><italic>Viharaja Nidanas</italic> like excessive coitus (<italic>Ati maithuna</italic>), untimely coitus (<italic>Akala maithuna</italic>), coitus in other than vagina (<italic>Ayouvana maithuna</italic>), abstinence, intercourse with unaroused partner, coitus in old age (<italic>Jaraya Gamana</italic>), excessive exercise (<italic>Ati Vyayama</italic>), excessive exposure to heat (<italic>Ati-Ushna sevana</italic>),[<xref ref-type="bibr" rid="ref25">25</xref>] and suppression of ejaculation (<italic>Shukravega Nigrahaha</italic>) are said to be responsible for the <italic>Shukravaha sroto dushti</italic>, which leads to <italic>Kshina Shukra</italic>.</p><p>The psychological causative factors are <italic>Chinta</italic> (worry), <italic>Bhaya</italic> (fear),[<xref ref-type="bibr" rid="ref20">20</xref>] <italic>Krodha</italic> (anger), <italic>Shoka</italic> (depression), and so on, and unhealthy sexual/coital practices. Iatrogenic causative factors include improper <italic>Kshara</italic> (Alkali),[<xref ref-type="bibr" rid="ref26">26</xref>] <italic>Agni</italic> (cauterization), and <italic>Sastra Karma</italic> (surgical procedures), anti-psychotic drugs such as[<xref ref-type="bibr" rid="ref27">27</xref>] Cyproterone, Ketoconazole, and the like, disease-Induced factors include &#x02014; diseases such as Hemorrhoids, Varicocele and so on, and other factors like smoking[<xref ref-type="bibr" rid="ref28">28</xref>] and caffeine are also known causative factors of oligozoospermia.</p><p>The pathogenesis of <italic>Kshina Shukra</italic> is not mentioned in the classics, but it is stated that the vitiation of <italic>Vata</italic> and <italic>Pitta Dosha</italic>, is responsible for the manifestation of <italic>Shukrakshaya</italic>.[<xref ref-type="bibr" rid="ref29">29</xref>] <italic>Mithyahara Vihara Sevana</italic> leads to <italic>Agnimandya</italic> as well as <italic>Amotpatti</italic>, hence, laeding to an improper formation of <italic>Ahara Rasa</italic>; which further leads to <italic>Rasa Kshaya</italic> due to the fault of <italic>Jatharagni</italic>, resulting in the depletion of the successive <italic>Dhatus</italic> and ending in <italic>Shukrakshaya</italic>. It has been said that the etiological factor affecting the <italic>Dhatus</italic> may also disturb the <italic>Doshas</italic>. This may also happen vice-versa. The <italic>Nidanas</italic> lead to <italic>Doshadushti</italic>, <italic>Khavaigunya</italic>, <italic>Dushya-daurbalya</italic>, and <italic>Dhatvagnimandya</italic>. This may happen simultaneously or gradually. In this case of <italic>Kshina shukra</italic>, the provocation of <italic>Vata</italic> and <italic>Pitta</italic> damages the <italic>Shukradhatu</italic> also, causing <italic>Shukradhatu Daurbalya</italic> and <italic>Shukravaha Srotodushti</italic>.</p><p><italic>Acharya</italic> Sushruta has indicated that <italic>Lakshanas</italic> of <italic>Shukrakshaya</italic> should be considered as that of <italic>Kshina Shukra</italic>.[<xref ref-type="bibr" rid="ref7">7</xref>] It must also be noted that Dalhana has described <italic>Kshina Shukra</italic> as <italic>Swa-Maanat Alpibhuta Shukra</italic>, which means the <italic>Shukra</italic> is of sub-normal parameters and this may be in terms of <italic>Dravyataha</italic> (by substance), <italic>Gunataha</italic> (by property), or <italic>Karmataha</italic> (by action). Hence, it is clear that many other symptoms of <italic>Shukrakshaya</italic> or <italic>Kshina Shukra</italic> may not be available in the patients, due to the selective <italic>Kshaya</italic> of sperm count. Hence, it is clear that except for a decrease in sperm count; the symptoms of <italic>Kshina Shukra</italic> may not be well-appreciated in patients. The sperms are nowhere related to the sexual and physical parameters.</p><p><italic>Nidana Parivarjana</italic> (cessation of causative factors)[<xref ref-type="bibr" rid="ref30">30</xref>] and <italic>Panchakarma</italic>[<xref ref-type="bibr" rid="ref31">31</xref>] are recommended for treating the malady <italic>Kshina Shukra</italic>, before administrating the <italic>Vajikarana</italic> therapy. The main line of treatment in <italic>Kshina Shukra</italic> has been suggested to be &#x02018;<italic>Kshine Shukrakari Kriya</italic>,&#x02019;[<xref ref-type="bibr" rid="ref32">32</xref>] and <italic>Upachaya</italic>[<xref ref-type="bibr" rid="ref33">33</xref>] is the primary line of treatment. It can also be managed by a line of treatment advocated for <italic>Shukravaha Srotodushti</italic> and <italic>Dushtashukra Rogas</italic>. <italic>Doshapratyanika Chikitsa</italic> can be adopted, that is, <italic>Vataja</italic> and <italic>Pittaja Shukradushti</italic> for the better management of <italic>Kshina Shukra</italic>. The drugs that have <italic>Madhura Rasa</italic> (Sweet), <italic>Snigdha</italic>, <italic>Guru Guna</italic> (unctuous and heavy quality), <italic>Jivana</italic> (promotes quality of life), and <italic>Brimhana</italic> (nourishing property) are highly recommended for the management of <italic>Kshina Shukra</italic>.</p><sec id="sec2-18"><title>Opening of the blinding</title><p>The Blinding Committee of the Department, in the presence of Scholar and guide, opened the sealed cover containing the information on blinding after the statistical analysis of the collected data was completed. On unmasking it, it was found that Group A consisted of Placebo granules and Group B had <italic>Gokshura</italic> Granules.</p></sec><sec id="sec2-19"><title>Probable mode of action of <italic>Gokshura</italic> granules</title><p><italic>Gokshura</italic> has <italic>Madhura rasa</italic> (sweet), <italic>Guru</italic> and <italic>Snigdha guna</italic> (unctuous and heavy quality), <italic>Sheeta Virya</italic> (Cold in Potency), <italic>Vrishya</italic> (Aphrodisiac), <italic>Rasayana</italic> (Rejuvinator), <italic>Brimhana</italic> (Nourishing therapy), and <italic>Vatapittahara</italic> properties.[<xref ref-type="bibr" rid="ref34">34</xref>] <italic>Vatapittahara Karma</italic> does the <italic>Samprapti Vightatana</italic> in the <italic>Kshina Shukra</italic>, as it is a <italic>Vata</italic>- and <italic>Pitta</italic>-predominant disease. However, <italic>Madhura Rasa</italic>, <italic>Snigdha</italic>, and <italic>Guru Guna</italic> increase the <italic>Shukra Dhatu</italic> qualitatively and quantitatively. <italic>Gokshura</italic> is known for its utility in <italic>Mutravaha Srotas</italic>,[<xref ref-type="bibr" rid="ref9">9</xref>] by correction of the <italic>Apana Vata</italic>, it exerts action on the <italic>Shukra</italic> also, along the lines similar to how <italic>Shukra Visarga</italic> is goverened by <italic>Apana Vata</italic>.</p><p><italic>Tribulus terrestris</italic> contains three groups of active phytochemicals. They are Dioscin, protodioscin, and diosgenin. Protodioscin is a potent natural precursor of the testosterone enhancer.[<xref ref-type="bibr" rid="ref35">35</xref>] It also increases the production of Testosterone in another natural way. <italic>Tribulus</italic> leads to the production of the luteinizing hormone (LH). When the LH levels are increased, the natural production of testosterone also increases. LH is a hormone that also deals with sex drive. LH has been used to increase fertility and helps to relieve impotence.[<xref ref-type="bibr" rid="ref35">35</xref>]</p></sec><sec id="sec2-20"><title>Probable mode of action of placebo</title><p>In present study barley powder was selected as the Placebo. The knowledge imparted regarding sexuality and fertility may be the reason behind the action of placebo, as psychological counseling has profound benefits on <italic>Shukra</italic>. The placebo effects presumably have different mediators depending on the specific learned association and whether it is referring to acquisition of the association or the placebo response. The central nervous system (CNS) is the primary location and mediator of the physiological basis of the placebo effect, through its role in learning and memory and its outputs on the sensory, motor, and autonomic pathways, as well as the immune and endocrine systems. People have individual traits that predispose them to be more or less responsive to certain stimuli; the interaction between the learned associations of the clinical situation and the person's particular biology produces a response. The response could be a basic physiological process, such as the modulation of sensory processing, release of neurotransmitters, or alterations in the hypothalamic&#x02013;pituitary&#x02013;adrenal axis or immune system activity. The placebo response could also be a slightly more complex physiological process, including change in mood, change in motivation/effort, or cognitive set-shifting.[<xref ref-type="bibr" rid="ref36">36</xref>] Jon-Kar Zubieta published findings that the nucleus accumbens is central to the machinery of the placebo effect. His group has confirmed that specific neural circuits and neurotransmitter systems respond to the expectation of benefit during placebo administration, and that these expectations induce measurable physiological changes.[<xref ref-type="bibr" rid="ref37">37</xref>]</p><p><italic>Koshtha Shuddhi</italic> with <italic>Eranda Taila</italic> was carried out prior to administration of the granules. The <italic>Vatanulomana</italic> exerted by <italic>Eranda Taila</italic> corrects the gastrointestinal functioning by its properties of <italic>Deepana</italic> (Appetizer) and <italic>Pachana</italic> (Carminative).[<xref ref-type="bibr" rid="ref38">38</xref>] <italic>Eranda Taila</italic> is widely prescribed as a <italic>Vatahara</italic>. <italic>Koshtha Shodhana</italic> increases the digestion and absorption of food and nutrients. Better bioavailability of food causes better nutrition to the <italic>Dhatus</italic>. <italic>Vatanulomana</italic>, especially correction of <italic>Apana Vata</italic> has its own benefits in <italic>Kshina Shukra</italic>. These are the possible mechanisms behind the placebo effect in the present study.</p></sec></sec><sec sec-type="conclusion" id="sec1-7"><title>Conclusion</title><p>After detailed discussion on observations made and results achieved, this present study shows significant remission in the signs and symptoms of <italic>Kshina Shukra</italic>, vis-&#x000e0;-vis oligozoospermia, corroborated with definite improvement in the total sperm count. <italic>In toto</italic>, from this study it can be concluded that the Alternate Hypothesis of this study is accepted, that is, <italic>Gokshura</italic> is effective in the management of <italic>Kshina Shukra</italic>, with lifestyle modification. <italic>Gokshura</italic> Granules have shown superior results in the management of <italic>Kshina Shukra</italic>, as compared to placebo granules.</p></sec></body><back><ref-list><ref id="ref1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Inhorn</surname><given-names>MC</given-names></name></person-group><article-title>Global infertility and the globalization of new reproductive technologies: Lllustrations from Egypt</article-title><source>Soc Sci Med</source><year>2003</year><volume>56</volume><fpage>1837</fpage><lpage>51</lpage><pub-id pub-id-type="pmid">12650724</pub-id></element-citation></ref><ref id="ref2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mehta</surname><given-names>RH</given-names></name><name><surname>Makwana</surname><given-names>S</given-names></name><name><surname>Ranga</surname><given-names>GM</given-names></name><name><surname>Srinivasan</surname><given-names>RJ</given-names></name><name><surname>Virk</surname><given-names>SS</given-names></name></person-group><article-title>Prevalence of Oligozoospermia and azoospermia in male partners of infertile couples from different parts of India</article-title><source>Asian J Androl</source><year>2006</year><volume>8</volume><fpage>89</fpage><lpage>93</lpage><pub-id pub-id-type="pmid">16372124</pub-id></element-citation></ref><ref id="ref3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meletis</surname><given-names>CD</given-names></name><name><surname>Barker</surname><given-names>J</given-names></name></person-group><article-title>Natural ways to enhance male fertility</article-title><source>Alternative and Complementary Therapies</source><year>2004</year><volume>10</volume><fpage>22</fpage><lpage>7</lpage></element-citation></ref><ref id="ref4"><label>4</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Norris</surname><given-names>S</given-names></name></person-group><article-title>Reproductive infertility: Prevalence, causes, trends and treatments</article-title><source>PRB-00-32E</source><year>2001</year><date-in-citation>Accessed on 2011 October 30</date-in-citation><publisher-loc>Ottawa</publisher-loc><publisher-name>Parliamentary Information and Research Service, Library of Parliament</publisher-name><comment>Available from <uri xlink:type="simple" xlink:href="http://www.parl.gc.ca/Content/LOP/researchpublications/prb0035-e.pdf">http://www.parl.gc.ca/Content/LOP/researchpublications/prb0035-e.pdf</uri></comment></element-citation></ref><ref id="ref5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sharlip</surname><given-names>ID</given-names></name><name><surname>Jarow</surname><given-names>JP</given-names></name><name><surname>Belker</surname><given-names>AM</given-names></name><name><surname>Lipshultz</surname><given-names>LI</given-names></name><name><surname>Sigman</surname><given-names>M</given-names></name><name><surname>Thomas</surname><given-names>AJ</given-names></name><etal/></person-group><article-title>Best practice policies for male infertility</article-title><source>Fertil Steril</source><year>2002</year><volume>77</volume><fpage>873</fpage><lpage>82</lpage><pub-id pub-id-type="pmid">12009338</pub-id></element-citation></ref><ref id="ref6"><label>6</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Baghel</surname><given-names>MS</given-names></name></person-group><person-group person-group-type="editor"><name><surname>Jain</surname><given-names>GK</given-names></name></person-group><article-title>Researches in Ayurveda</article-title><year>2005</year><edition>2nd ed</edition><publisher-loc>Jamnagar</publisher-loc><publisher-name>Mridu Ayurveda Publication and Sales</publisher-name></element-citation></ref><ref id="ref7"><label>7</label><element-citation publication-type="book"><person-group person-group-type="editor"><name><surname>Sushruta</surname></name><name><surname>Sushruta</surname><given-names>Samhita</given-names></name><name><surname>Vaidya Jadavji</surname><given-names>Trikamji Acharya</given-names></name></person-group><source>Sharira Sthana, Shukrashonita Shuddhisharira, 2/4</source><year>2007</year><edition>9th ed</edition><publisher-loc>Varanasi</publisher-loc><publisher-name>Chaukhamba Orientalia</publisher-name><fpage>344</fpage></element-citation></ref><ref id="ref8"><label>8</label><element-citation publication-type="book"><collab>World Health Organization</collab><article-title>WHO Laboratory Manual for the Examination of Human Semen and Sperm Cervical Mucus Interaction</article-title><year>1999</year><volume>10</volume><edition>4th ed</edition><publisher-loc>Cambridge, United Kingdom</publisher-loc><publisher-name>Cambridge University Press</publisher-name><fpage>128</fpage></element-citation></ref><ref id="ref9"><label>9</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Sharma</surname><given-names>PC</given-names></name><name><surname>Yelne</surname><given-names>MB</given-names></name><name><surname>Dennis</surname><given-names>TJ</given-names></name></person-group><article-title>Data base on medicinal plants used in Ayurveda</article-title><year>2002</year><volume>3</volume><publisher-loc>New Delhi</publisher-loc><publisher-name>Central Council For Research In Aurveda and Siddha</publisher-name><fpage>229</fpage></element-citation></ref><ref id="ref10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pandya</surname><given-names>K</given-names></name><name><surname>Solanki</surname><given-names>B</given-names></name><name><surname>Maniar</surname><given-names>K</given-names></name><name><surname>Gurav</surname><given-names>N</given-names></name><name><surname>Bhatt</surname><given-names>S</given-names></name></person-group><article-title>Natural herbal supplements- A study on their nutritional value and their phytochemical constituents</article-title><source>International Journal of Pharmaceutical Sciences and Research</source><year>2011</year><volume>2</volume><fpage>1480</fpage><lpage>94</lpage></element-citation></ref><ref id="ref11"><label>11</label><element-citation publication-type="book"><collab>Anonymus</collab><article-title>Selected medicinal plants of India. A monograph Published by scientists at Bhavan's Swami Prakashananda Ayurvedic Research Centre</article-title><source>A monograph of identity, safety and clinical usage</source><year>1992</year><publisher-loc>Mumbai</publisher-loc><publisher-name>CHEMEXCIL</publisher-name><fpage>325</fpage></element-citation></ref><ref id="ref12"><label>12</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Bhavamishra</surname></name><name><surname>Bhavaprakash</surname><given-names>Nighantu</given-names></name></person-group><person-group person-group-type="editor"><name><surname>Dr. Chunekar</surname><given-names>K.C</given-names></name><name><surname>Dr. Pandey</surname><given-names>G.S</given-names></name></person-group><year>2004</year><edition>Reprint</edition><publisher-loc>Varanasi</publisher-loc><publisher-name>Chaukambha Sanskrit Sansthan</publisher-name><fpage>292</fpage></element-citation></ref><ref id="ref13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schulz</surname><given-names>KF</given-names></name><name><surname>Altman</surname><given-names>DG</given-names></name><name><surname>Moher</surname><given-names>D</given-names></name></person-group><article-title>CONSORT 2010 Statement: Updated guidelines for reporting parallel group randomised trials</article-title><source>BMJ</source><year>2010</year><volume>340</volume><fpage>c332</fpage><comment>for the CONSORT Group</comment><pub-id pub-id-type="pmid">20332509</pub-id></element-citation></ref><ref id="ref14"><label>14</label><element-citation publication-type="webpage"><year>2011</year><month>7</month><day>20</day><comment>Available from: <uri xlink:type="simple" xlink:href="http://www.ctri.nic.in">http://www.ctri.nic.in</uri></comment></element-citation></ref><ref id="ref15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Costa</surname><given-names>P</given-names></name><name><surname>Arnould</surname><given-names>B</given-names></name><name><surname>Cour</surname><given-names>F</given-names></name><name><surname>Boyer</surname><given-names>P</given-names></name><name><surname>Marrel</surname><given-names>A</given-names></name><name><surname>Jaudinot</surname><given-names>EO</given-names></name><etal/></person-group><article-title>Quality of Sexual Life Questionnaire (QVS): A reliable, sensitive and reproducible instrument to assess quality of life in subjects with erectile dysfunction</article-title><source>Int J Impot Res</source><year>2003</year><date-in-citation>Last accessed on 2010 Feb 1</date-in-citation><volume>15</volume><fpage>173</fpage><lpage>84</lpage><comment>2003 Available from: <uri xlink:type="simple" xlink:href="http://www.nature.com/ijir">http://www.nature.com/ijir</uri></comment><pub-id pub-id-type="pmid">12904803</pub-id></element-citation></ref><ref id="ref16"><label>16</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Mahajan</surname><given-names>BK</given-names></name></person-group><article-title>Methods</article-title><source>Biostatistics for medical students and research workers</source><year>2006</year><edition>6th ed</edition><publisher-loc>New Delhi</publisher-loc><publisher-name>J P Brothers medical publishers limited</publisher-name><fpage>168</fpage><lpage>85</lpage></element-citation></ref><ref id="ref17"><label>17</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Agnivesha</surname></name></person-group><person-group person-group-type="editor"><name><surname>Yadavji Trikamji</surname><given-names>Acharya</given-names></name></person-group><source>Charaka, Dridhabala, Charaka Samhita</source><year>2001</year><edition>5th ed</edition><publisher-loc>Varanasi</publisher-loc><publisher-name>Chaukhamba Surbharati Prakashan</publisher-name><fpage>303</fpage><comment>Sharira Sthana, Atulyagotriyam, 2/18</comment></element-citation></ref><ref id="ref18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Poongothai</surname><given-names>J</given-names></name><name><surname>Gopenath</surname><given-names>TS</given-names></name><name><surname>Manonayaki</surname><given-names>S</given-names></name></person-group><article-title>Genetics of human male infertility</article-title><source>Singapore Med J</source><year>2009</year><volume>50</volume><fpage>336</fpage><lpage>47</lpage><pub-id pub-id-type="pmid">19421675</pub-id></element-citation></ref><ref id="ref19"><label>19</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Agnivesha</surname></name></person-group><person-group person-group-type="editor"><name><surname>Yadavji Trikamji</surname><given-names>Acharya</given-names></name></person-group><source>Charaka, Dridhabala, Charaka Samhita</source><year>2001</year><edition>5th ed</edition><publisher-loc>Varanasi</publisher-loc><publisher-name>Chaukhamba Surbharati Prakashan</publisher-name><fpage>397</fpage><comment>Chikitsa Sthana, Vijikaran Adhyaya, Puman Jatabaladikam- Vijikaran Padam, 2/4/43</comment></element-citation></ref><ref id="ref20"><label>20</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Agnivesha</surname></name></person-group><person-group person-group-type="editor"><name><surname>Yadavji Trikamji</surname><given-names>Acharya</given-names></name></person-group><source>Charaka, Dridhabala, Charaka Samhita</source><year>2001</year><edition>5th ed</edition><publisher-loc>Varanasi</publisher-loc><publisher-name>Chaukhamba Surbharati Prakashan</publisher-name><fpage>103</fpage><comment>Sutra Sthana, Kiyant Shirsiyam Adhyaya, 17/76</comment></element-citation></ref><ref id="ref21"><label>21</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Agnivesha</surname></name></person-group><person-group person-group-type="editor"><name><surname>Yadavji Trikamji</surname><given-names>Acharya</given-names></name></person-group><source>Charaka, Dridhabala, Charaka Samhita</source><year>2001</year><edition>5th ed</edition><publisher-loc>Varanasi</publisher-loc><publisher-name>Chaukhamba Surbharati Prakashan</publisher-name><fpage>641</fpage><comment>Chikitsa Sthana, Yoni Yvapat Chikitsadhyaya, 30/164-167</comment></element-citation></ref><ref id="ref22"><label>22</label><element-citation publication-type="book"><person-group person-group-type="editor"><name><surname>Sushruta</surname></name><name><surname>Sushruta</surname><given-names>Samhita</given-names></name><name><surname>Vaidya Jadavji</surname><given-names>Trikamji Acharya</given-names></name></person-group><year>2007</year><edition>9th ed</edition><publisher-loc>Varanasi</publisher-loc><publisher-name>Chaukamba Orientalia</publisher-name><fpage>69</fpage><comment>Sutra Sthana, Doshadhatumalakshayavriddhi Vijnyaniya, 15/9</comment></element-citation></ref><ref id="ref23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>SR</given-names></name><name><surname>Chhetri</surname><given-names>MK</given-names></name><name><surname>Johanson</surname><given-names>J</given-names></name><name><surname>Radfar</surname><given-names>N</given-names></name><name><surname>Migeon</surname><given-names>CJ</given-names></name></person-group><article-title>The pituitarygonadal axis in men with protein-calorie malnutrition</article-title><source>J Clin Endocrinol Metab</source><year>1975</year><volume>41</volume><fpage>60</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">807594</pub-id></element-citation></ref><ref id="ref24"><label>24</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Agnivesha</surname></name></person-group><person-group person-group-type="editor"><name><surname>Yadavji Trikamji</surname><given-names>Acharya</given-names></name></person-group><source>Charaka, Dridhabala, Charaka Samhita</source><year>2001</year><edition>5th ed</edition><publisher-loc>Varanasi</publisher-loc><publisher-name>Chaukhamba Surbharati Prakashan</publisher-name><fpage>143</fpage><comment>Sutra Sthana, Aatrya Bhadrakapiya Adhyaya, 26/43-44</comment></element-citation></ref><ref id="ref25"><label>25</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Agnivesha</surname></name></person-group><person-group person-group-type="editor"><name><surname>Yadavji Trikamji</surname><given-names>Acharya</given-names></name></person-group><source>Charaka, Dridhabala, Charaka Samhita</source><year>2001</year><edition>5th ed</edition><publisher-loc>Varanasi</publisher-loc><publisher-name>Chaukhamba Surbharati Prakashan</publisher-name><fpage>640</fpage><comment>Chikitsa Sthana, Yoniyvapat Chikitsadhyaya, 30/135-138</comment></element-citation></ref><ref id="ref26"><label>26</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Agnivesha</surname></name></person-group><person-group person-group-type="editor"><name><surname>Yadavji Trikamji</surname><given-names>Acharya</given-names></name></person-group><source>Charaka, Dridhabala, Charaka Samhita</source><year>2001</year><edition>5th ed</edition><publisher-loc>Varanasi</publisher-loc><publisher-name>Chaukhamba Surbharati Prakashan</publisher-name><fpage>503</fpage><comment>Chikitsa Sthana, Arsha Chikitsa, 14/34</comment></element-citation></ref><ref id="ref27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blair</surname><given-names>J</given-names></name><name><surname>Simpson</surname><given-names>G</given-names></name></person-group><article-title>Effects of Antipsychotic drugs on reproductive functions</article-title><source>Dis Nerv Syst</source><year>1966</year><volume>27</volume><fpage>645</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">4380665</pub-id></element-citation></ref><ref id="ref28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Banerjee</surname><given-names>A</given-names></name><name><surname>Pakrashi</surname><given-names>A</given-names></name><name><surname>Chatterjee</surname><given-names>S</given-names></name><name><surname>Ghosh</surname><given-names>S</given-names></name><name><surname>Dutta</surname><given-names>SK</given-names></name></person-group><article-title>Semen characteristics of tobacco users in India</article-title><source>Arch Androl</source><year>1993</year><volume>30</volume><fpage>35</fpage><lpage>40</lpage><pub-id pub-id-type="pmid">8420503</pub-id></element-citation></ref><ref id="ref29"><label>29</label><element-citation publication-type="book"><person-group person-group-type="editor"><name><surname>Sushruta</surname></name><name><surname>Sushruta</surname><given-names>Samhita</given-names></name><name><surname>Vaidya Jadavji</surname><given-names>Trikamji Acharya</given-names></name></person-group><year>2007</year><edition>9th ed</edition><publisher-loc>Varanasi</publisher-loc><publisher-name>Chaukamba Orientalia</publisher-name><fpage>74</fpage><comment>Sutra Sthana, Doshadhatumalakshayavriddhi Vijnyaniya,15/9</comment></element-citation></ref><ref id="ref30"><label>30</label><element-citation publication-type="book"><person-group person-group-type="editor"><name><surname>Sushruta</surname></name><name><surname>Sushruta</surname><given-names>Samhita</given-names></name><name><surname>Vaidya Jadavji</surname><given-names>Trikamji Acharya</given-names></name></person-group><year>2007</year><edition>9th ed</edition><publisher-loc>Varanasi</publisher-loc><publisher-name>Chaukamba Orientalia</publisher-name><fpage>597</fpage><comment>Uttara Tantra, Aupadravikam Adhyaya, 1/25</comment></element-citation></ref><ref id="ref31"><label>31</label><element-citation publication-type="book"><person-group person-group-type="editor"><name><surname>Agnivesha</surname></name></person-group><person-group person-group-type="editor"><name><surname>Yadavji Trikamji</surname><given-names>Acharya</given-names></name></person-group><source>Charaka, Dridhabala, Charaka Samhita</source><year>2001</year><edition>5th ed</edition><publisher-loc>Varanasi</publisher-loc><publisher-name>Chaukhamba Surbharati Prakashan</publisher-name><fpage>640</fpage><comment>Chikitsa Sthana, Yoniyvapat Chikitsadhyaya, 30/126-127</comment></element-citation></ref><ref id="ref32"><label>32</label><element-citation publication-type="book"><person-group person-group-type="editor"><name><surname>Vagbhata</surname></name><name><surname>Ashtanaga</surname><given-names>Hridaya</given-names></name><name><surname>Dr. Anna Moreshwar</surname><given-names>Kunte</given-names></name></person-group><year>2002</year><publisher-loc>Varanasi</publisher-loc><publisher-name>Chaukambha Surabharati prakashana</publisher-name><fpage>365</fpage><comment>Sharira Sthana, Garbhavakranti Adhyaya, 1/14</comment></element-citation></ref><ref id="ref33"><label>33</label><element-citation publication-type="book"><person-group person-group-type="editor"><name><surname>Sushruta</surname></name><name><surname>Sushruta</surname><given-names>Samhita</given-names></name><name><surname>Vaidya Jadavji</surname><given-names>Trikamji Acharya</given-names></name></person-group><year>2007</year><edition>9th ed</edition><publisher-loc>Varanasi</publisher-loc><publisher-name>Chaukamba Orientalia</publisher-name><fpage>2</fpage><lpage>3</lpage><comment>Sutra Sthana, Vedotpatti Adhyaya, 1/7</comment></element-citation></ref><ref id="ref34"><label>34</label><element-citation publication-type="book"><collab>Anonymus</collab><article-title>The Ayurvedic Pharmacopoeia of India</article-title><issue>Part-I, Vol I</issue><publisher-loc>New Delhi</publisher-loc><publisher-name>Ministry of Health And Family Welfare, Department of AYUSH, Government of India</publisher-name><fpage>40</fpage></element-citation></ref><ref id="ref35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gauthaman</surname><given-names>K</given-names></name><name><surname>Adaikan</surname><given-names>PG</given-names></name><name><surname>Prasad</surname><given-names>RN</given-names></name></person-group><article-title>Aphrodisiac properties of Tribulus Terrestris extract (Protodioscin) in normal and castrated rats</article-title><source>Life Sci</source><year>2002</year><volume>71</volume><fpage>1385</fpage><lpage>96</lpage><pub-id pub-id-type="pmid">12127159</pub-id></element-citation></ref><ref id="ref36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oken</surname><given-names>BS</given-names></name></person-group><article-title>Placebo effects: Clinical aspects and neurobiology</article-title><source>Brain</source><year>2008</year><volume>131</volume><fpage>2812</fpage><lpage>23</lpage><pub-id pub-id-type="pmid">18567924</pub-id></element-citation></ref><ref id="ref37"><label>37</label><element-citation publication-type="webpage"><collab>Brain region central to placebo effect identified</collab><date-in-citation>Last accessed on Nov 01, 2011</date-in-citation><comment>Available from: <uri xlink:type="simple" xlink:href="http://www.eurekalert.org/pub_releases/2007-07/cp-brc071607.php">http://www.eurekalert.org/pub_releases/2007-07/cp-brc071607.php</uri></comment></element-citation></ref><ref id="ref38"><label>38</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Bhavamishra</surname></name><name><surname>Bhavaprakash</surname><given-names>Nighantu</given-names></name></person-group><person-group person-group-type="editor"><name><surname>Dr. Chunekar</surname><given-names>K.C</given-names></name><name><surname>Dr. Pandey</surname><given-names>G.S</given-names></name></person-group><year>2004</year><edition>Reprint</edition><publisher-loc>Varanasi</publisher-loc><publisher-name>Chaukambha Sanskrit Sansthan</publisher-name><fpage>781</fpage></element-citation></ref></ref-list></back></article>